Antilipemic Drugs Flashcards

1
Q

Atorvastatin (Lipitor)

Chemical Classification

A

HMG-CoA reductase inhibitor (statin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Atorvastatin (Lipitor)

Mechanism of Action

A

Inhibits HMG-CoA reductase enzyme, which reduces cholesterol synthesis; high doses lead to plaque regression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Atorvastatin (Lipitor)

Uses

A

As adjunct for primary hypercholesterolemia (types Ia, Ib), dysbetalipoproteinemia, elevated triglyceride levels, prevention of CV disease by reduction of heart risk in those with mildly elevated cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Atorvastatin (Lipitor)

Contraindications

A

Pregnancy (X), breastfeeding, hypersensitivity, active hepatic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Atorvastatin (Lipitor)

Side Effects

A
CNS: headache, asthenia
EENT: lens opacities
GI: Abdominal Cramps, Constipation, Diarrhea, Flatus, Heartburn, dyspepsia, LIVER DYSFUNCTION, PANCREATITIS, nausea, increased serum transaminase 
GU: impotence
INTEG: rash, pruritus, alopecia; photosensitivity (rare)
MISC: hypersensitivity 
MS: arthralgia, myalgia, RHABDOMYOLYSIS 
RESP: pharyngitis, sinusitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Atorvastatin (Lipitor)

Nursing Considerations

A

ASSESS:

  • HYPERCHOlESTEROLEMIA: diet, obtain diet history including fat, cholesterol in diet; cholesterol triglyceride levels periodically during treatment; check lipid panel 6-12wk after changing dose
  • Hepatic studies q1-2mo, at initiation, 6,12wk after initiation or change in dose, periodically thereafter; AST, ALT, LFTs may be increased
  • Renal studies in patients with compromised renal system: BUN, I&O ratio, creatinine
  • Bowel status: constipation, stool softeners may be needed; if severe, add fiber, water to diet
  • RHABDOMYOLYSIS: FOR MUSCLE PAIN, TENDERNESS, OBTAIN CPK BASELINE; IF MARKEDLY INCREASED, PRODUCT MAY NEED TO BE DISCONTINUED
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cholestyramine (Questran)

Functional Classification

A

Antilipemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cholestyramine (Questran)

Chemical Classification

A

Bile Acid Sequestrant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cholestyramine (Questran)

Mechanism of Action

A

Absorbs, combines with bile acids to form insoluble complex that is excreted through feces; loss of bile acids lowers LDL, cholesterol levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cholestyramine (Questran)

Uses

A

Primary hypercholesterolemia (esp. type IIa/IIb hyperlipoproteinemia), pruritus associated with biliary obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cholestyramine (Questran)

Contraindications

A

Hypersensitivity; biliary obstruction; hyperlipidemia III, IV, V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cholestyramine (Questran)

Side Effects

A

CNS: headache, dizziness, drowsiness, vertigo, tinnitus, anxiety
GI: Constipation, Abdominal Pain, Nausea, fecal impaction, hemorrhoids, flatulence, vomiting, steatorrhea, peptic ulcer
HEMA: BLEEDING, increased PT
INTEG: rash, irritation of perianal area, tongue, skin
META: decreased vit A, D, K, red cell folate content; HYPERCHLOREMIC ACIDOSIS
MS: muscle, joint pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cholestyramine (Questran)

Nursing Considerations

A

ASSESS:

  • Cardiac glycoside level if both products administered
  • For signs of vit A, D, K deficiency
  • HYPERCHOLESTEROLEMIA: fasting LDL, HDL, total cholesterol, triglyceride levels, electrolytes if receiving extended therapy; diet history
  • PRURITUS: for signs of itching
  • Bowel pattern daily; increase bulk, water in diet for constipation; diarrhea may also occur
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Niacin

Functional Classification

A

Vit B3, antihyperlipidemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Niacin

Chemical Classification

A

Water-soluble vitamin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Niacin

Mechanism of Action

A

Needed for conversion of fats, protein, carbohydrates by oxidation reduction; acts directly on vascular smooth muscle, this causing vasodilation; reduces total cholesterol, LDL, VLDL, triglycerides; increases HDL

17
Q

Niacin

Uses

A

Pellagra, hyperlipidemias (types 4,5), peripheral vascular disease that presents a risk for pancreatitis

18
Q

Niacin

Contraindications

A

Breastfeeding, hypersensitivity, peptic ulcer, hepatic disease, hemorrhage, severe hypotension

19
Q

Niacin

Side Effects

A

CNS: paresthesias, headache, dizziness, anxiety
CV: postural hypotension, vasovagal attacks, dysrhythmias, vasodilation
EENT: blurred vision, ptosis
GI: nausea, vomiting, anorexia, JAUNDICE, HEPATOTOXICITY, diarrhea, peptic ulcer, dyspepsia, HEPATITIS
GU: hyperuricemia, GLYCOSURIA, HYPOALBUMINEMIA
INTEG: flushing, dry skin, rash, pruritus, itching, tingling

20
Q

Niacin

Nursing Considerations

A

ASSESS:

  • Cardiac status: rate, rhythm, quality; postural hypotension, dysrhythmias
  • Nutritional status: liver, yeast, legumes, organ meat, lean poultry; fat in diet
  • HEPATOTOXICITY: clay-colored stools, itching, dark urine, jaundice; hepatic studies: AST, ALT, bilirubin, uric acid, alk phos; blood glucose before and during treatment
  • CNS symptoms: headache, paresthesias, blurred vision
  • NIACIN DEFICIENCY: nausea, vomiting, anemia, poor memory, confusion, dermatitis
  • HYPERLIPIDEMIA: for lipid, triglyceride, cholesterol level; obtain diet history
21
Q

Simvastatin (Zocor)

Functional Classification

A

Antilipemic

22
Q

Simvastatin (Zocor)

Chemical Classification

A

HMG-CoA reductase inhibitor

23
Q

Simvastatin (Zocor)

Mechanism of Action

A

Inhibits HMG-CoA reductase enzyme, which reduces cholesterol synthesis

24
Q

Simvastatin (Zocor)

Uses

A

As an adjunct for primary hypercholesterolemia (types IIa, IIb), isolated hypertriglyceridemia (Frederickson type IV) and type III hyperlipoproteinemia, CAD, heterozygous familial hypercholesterolemia

25
Q

Simvastatin (Zocor)

Contraindications

A

Pregnancy (X), breastfeeding, hypersensitivity, active hepatic disease

26
Q

Simvastatin (Zocor)

Side Effects

A

CNS: headache
GI: nausea, constipation, diarrhea, dyspepsia, flatus, abdominal pain, LIVER DYSFUNCTION, PANCREATITIS
INTEG: rash, pruritus
MS: muscle cramps, myalgia, MYOSITIS, RHABDOMYOLYSIS, myopathy
RESP: upper respiratory tract infection

27
Q

Simvastatin (Zocor)

Nursing Considerations

A

ASSESS:

  • Diet history: fat consumption; baseline and lipid profile: LDL, HDL, TG, cholesterol
  • Hepatic studies at baseline, after 4-6wk, periodically thereafter; AST, ALT, LFTs may increase
  • RHABDOMYOLYSIS: muscle tenderness, increased CPK levels (10x above upper normal limit); therapy should be discontinued
  • Renal studies in patients with compromised renal systems: BUN, I&O ratio, creatinine
28
Q

Atorvastatin (Lipitor)

Functional Classification

A

Antilipidemic